Shares of Moderna, Inc. plunged over 20% on Monday to their lowest levels since mid-April 2020 and were on course to mark ...
Before beginning the discussion of where this company is going, let's set expectations appropriately. Moderna won't be ...
Moderna's stock plummeted to an almost five-year low after the biotech company cut its revenue outlook for this year and said that sales for last year will come in at the lower end of its guidance.
Moderna won't be revisiting its all-time highs for revenue or earnings in the next three years. The odds ... Today, Moderna's trailing-12-month revenue is just over $5 billion, and it reported ...